{"id":"W2618685600","doi":"10.1186/s12933-017-0552-4","title":"Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Ezetimibe; Fenofibrate; PCSK9; Internal medicine; Dyslipidemia; Statin; Type 2 diabetes; Endocrinology; Diabetes mellitus; Gastroenterology; Cholesterol; Lipoprotein; Apolipoprotein A1","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005227252,0.0004059663,0.002667308,0.000186678,0.0004257234,0.00003526208,0.0002759554,0.0003950935,0.000006821583],"category_scores_gemma":[0.001399103,0.0002926722,0.0007293106,0.0002353001,0.0009174028,0.0001540641,0.0004744692,0.0004386032,9.047261e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001045292,"about_ca_system_score_gemma":0.0002235886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002693685,"about_ca_topic_score_gemma":0.0000359095,"domain_scores_codex":[0.995932,0.001165509,0.0007477571,0.0008227083,0.0007969002,0.0005351712],"domain_scores_gemma":[0.9962164,0.0004526582,0.0004484926,0.002438755,0.000230548,0.0002131391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006436112,0.000245765,0.80302,0.002501014,0.03661532,0.00005384713,0.001059997,0.004809981,0.002085329,0.0001884431,0.0000963702,0.1428878],"study_design_scores_gemma":[0.05502873,0.0006326235,0.9264777,0.0005364104,0.004668878,0.00009487337,0.0000776431,0.0001068934,0.009248486,0.0001169481,0.002612002,0.0003988166],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9569787,0.03899346,0.0004994675,0.0001356514,0.000381311,0.00290955,0.00001923091,0.00002248468,0.00006017216],"genre_scores_gemma":[0.9932826,0.004813582,0.001413166,0.0000354246,0.0002468879,0.0001185927,0.00001554301,0.00006153737,0.0000126292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.142489,"threshold_uncertainty_score":0.9999526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01652227399736756,"score_gpt":0.2391748565043356,"score_spread":0.222652582506968,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}